Correction: Human candidate polymorphisms in sympatric ethnic groups differing in malaria susceptibility in Mali (PLoS ONE (2013) 8, 10, (e75675) DOI: 10.1371/journal.pone.0075675);Human Candidate Polymorphisms in Sympatric Ethnic Groups Differing in Malaria Susceptibility in Mali

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Maiga, Bakary ^a,g   Dolo, Amagana ^a   Touré, Ousmane ^a   Dara, Victor ^a   Tapily, Amadou ^a   Campino, Susana ^b   Sepulveda, Nuno ^c,d   Risley, Paul ^e   Silva, Nipula ^e   Corran, Patrick ^c,e   Rockett, Kirk A ^b,f   Kwiatkowski, Dominic ^b,f   Clark, Taane G ^c   Troye Blomberg, Marita ^g   Doumbo, Ogobara K ^a  

^a and Technologies of Bamako   (Mali)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF LISBON   (Portugal)

^e NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; CYSTEINE STRING PROTEIN; DNA; IMMUNOGLOBULIN E; MAJOR SURFACE PROTEIN 1; MAJOR SURFACE PROTEIN 2; MEMBRANE PROTEIN; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ADCY9 GENE; ADOLESCENT; AFRICA; ALLELE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; AXILLA TEMPERATURE; BLOOD ANALYSIS; BLOOD GROUP O; BODY WEIGHT; CD36 GENE; CHILD; CONTROLLED STUDY; DISEASE TRANSMISSION; ETHNIC GROUP; FCER1A GENE; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HUMAN; IL13 GENE; IL4 GENE; IMMUNOASSAY; INFANT; INFECTION SENSITIVITY; MALARIA; MALE; NONHUMAN; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; RAD50 GENE; RURAL AREA; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SLC22A4 GENE; SPLENOMEGALY; SYMPATRY; TNF GENE;

ADOLESCENT; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; CYTOKINES; DISEASE RESISTANCE; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; INFANT; INFANT, NEWBORN; MALARIA; MALE; MALI; PHENOTYPE; PLASMODIUM FALCIPARUM; POLYMORPHISM, SINGLE NUCLEOTIDE; SYMPATRY;

EID: 84884848454     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104358     Document Type: Erratum

References (46)

1. World Health Organization (2008). World Malaria Report: 2008. Geneva, Switzerland: World Health Organization.
2. World Health Organization (2011). World Malaria Report: 2011. Geneva, Switzerland: World Health Organization.
3. Mackinnon MJ, Mwangi TW, Snow RW, Marsh K, Williams TN, (2005) Heritability of malaria in Africa. PLOS Med 2: 2005. Epub 10.1371/journal.pmed.0020340. PubMed: 16259530.
4. Greenwood BM, Groenendaal F, Bradley AK, Greenwood AM, Shenton F, et al. (1987) Ethnic differences in the prevalence of splenomegaly and malaria in The Gambia. Ann Trop Med Parasitol 81: 345-354. PubMed: 3446025.
5. Bryceson ADM, Fleming AF, Edington GM, (1976) Splenomegaly in northern Nigeria. Acta Trop 33: 424-426. PubMed: 11654.
6. Modiano D, Petrarca V, Sirima BS, Luoni G, Nebie I, et al. (1999) Different response to Plasmodium falciparum in west African sympatric ethnic groups: possible implications for malaria control strategies. Parassitologia. 41: 193-197. Review. PubMed: 10697855.
7. Modiano D, Chiucchiuini A, Petrarca V, Sirima BS, Luoni G, et al. (1999) Interethnic differences in the humoral response to non-repetitive regions of the Plasmodium falciparum circumsporozoite protein. Am J Trop Med Hyg 61: 663-667. PubMed: 10548307.
8. Dolo A, Modiano D, Maiga B, Daou M, Dolo G, et al. (2005) Difference in susceptibility to malaria between two sympatric ethnic groups in Mali. Am J Trop Med Hyg 72: 243-248Retrieved onpublished at whilst December year 1111 from. PubMed: 15772314.
9. Toure O, Konate S, Sissoko S, Niangaly A, Barry A, et al.; Toure O, Konate S, Sissoko S, Niangaly A, Barry A, Sall AH, Diarra E, Poudiougou B, Sepulveda N, Campino S, Rockett KA, Clark TG, Thera MA, Doumbo O, Collaboration with The MalariaGEN Consortium (2012) Candidate polymorphisms and severe malaria in a Malian population. PLOS ONE. 7: e43987 doi:10.1371/journal.pone.0043987. PubMed: 22957039. Epub 2012 Sep 5. doi:10.1371/journal.pone.0043987. PubMed: 22957039.
10. Losos JB, (2000) May 23) Ecological character displacement and the study of adaptation. Proc Natl Acad Sci U S A;97(11):: 5693-5695. doi:10.1073/pnas.97.11.5693. PubMed: 10823930.
11. Modiano D, Chiucchiuini A, Petrarca V, Sirima BS, Luoni G, et al. (1998) Humoral response to Plasmodium falciparum Retrieved onpublished at whilst December year 1111 from Pf155/ring-infected erythrocyte surface antigen and Pf332 in three sympatric ethnic groups of Burkina Faso. Am J Trop Med Hyg. 58: 220-4.
12. Campino S, Kwiatkowski D, Dessein A, (2006) Mendelian and complex genetics of susceptibility and resistance to parasitic infections. Semin Immunol 18: 2006-422. Epub 10.1016/j.smim.2006.07.011.
13. Gazzinelli RT, Denkers EY, (2006) Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. Nat Rev Immunol Volumes 12: 2006-906. Epub 10.1038/nm1469.
14. Diallo DA, Doumbo OK, Plowe CV, Wellems TE, Emanuel EJ, et al. (2005) Community permission for medical research in developing countries. Clin Infect Dis;41(2):: 2005-259. Epub Erratum in: Clin Infect Dis (2005) Sep 15);41(6): 15983925.
15. Hackett Lw. (1944). Spleen measurement in malaria. J Nat Mal Soc, 3: pp. 11-13.
16. Zhang L, Cui X, Schmitt K, Hubert R, Navidi W, et al. (1992) Whole genome amplification from a single cell: implications for genetic analysis. Proc Natl Acad Sci U S A; 89: 5847-5851. doi:10.1073/pnas.89.13.5847. PubMed: 1631067.
17. Ross P, Hall L, Smirnov I, Haff L, (1998) High level multiplex genotyping by MALDI-TOF mass spectrometry. Nat Biotechnol; 16: 1347-1351. doi:10.1038/4328. PubMed: 9853617.
18. Wilson JN, Rockett K, Jallow M, Pinder M, Sisay-Joof F, et al. (2005) Analysis of IL10 haplotypic associations with severe malaria. Genes Immun 6: 462-466. doi:10.1038/sj.gene.6364227. PubMed: 15933743.
19. Corran PH, Cook J, Lynch C, Leendertse H, Manjurano A, et al. (2008) Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J 7: 195. doi:10.1186/1475-2875-7-195. PubMed: 18826573.
20. Snyder DB, Marquardt WW, Mallinson ET, Russek E, (1983) Rapid serological profiling by enzyme linked immunosorbent assay. I. Measurement of antibody activity titre against Newcastle disease virus in a single serum dilution. Avian Dis 27: 161-170. doi:10.2307/1590381. PubMed: 6342592.
21. Weir B, Cockerham C, (1984) Estimating F statistics for the analysis of population structure. Evolution 38: 1358-1370. doi:10.2307/2408641.
22. Aitman TJ, Cooper LD, Norsworthy PJ, Wahid FN, Gray JK, et al. (2000) Malaria susceptibility and CD36 mutation. Nature 405: 1015-1016. doi:10.1038/35016636. PubMed: 10890433.
23. Rowe JA, Handel IG, Thera MA, Deans AM, Lyke KE, et al. (2007) Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc Natl Acad Sci U S A 104: 17471-17476. Epub 10.1073/pnas.0705390104. PubMed: 17959777.
24. Fry AE, Ghansa A, Small KS, Palma A, Auburn S, et al.; Fry AE, Ghansa A, Small KS, Palma A, Auburn S, Diakite M, Green A, Campino S, Teo YY, Clark TG, Jeffreys AE, Wilson J, Jallow M, Sisay-Joof F, Pinder M, Griffiths MJ, Peshu N, Williams TN, Newton CR, Marsh K, Molyneux ME, Taylor TE, Koram KA, Oduro AR, Rogers WO, Rockett KA, Sabeti PC, Kwiatkowski DP, (2009) Positive selection of a CD36 nonsense variant in sub-Saharan Africa, but no association with severe malaria phenotypes. Hum Mol Genet 18: 2683-2692. Epub(2009) Apr 29. doi:10.1093/hmg/ddp192. PubMed: 19403559.
25. Eid NA, Hussein AA, Elzein AM, Mohamed HS, Rockett KA, et al. (2010) Candidate malaria susceptibility/protective SNPs in hospital and population-based studies: the effect of sub-structuring. Malar J 9: 119. doi:10.1186/1475-2875-9-119. PubMed: 20459687.
26. Kwiatkowski D, (2000) Genetic susceptibility to malaria getting complex. Curr Opin Genet Dev, 10: 320-324. doi:10.1016/S0959-437X(00)00087-3. PubMed: 10826994.
27. Manjurano A, Clark TG, Nadjm B, Mtove G, Wangai H, et al.; Manjurano A, Clark TG, Nadjm B, Mtove G, Wangai H, Sepulveda N, Campino SG, Maxwell C, Olomi R, Rockett KR, Jeffreys A, MalariaGen Consortium, Riley EM, Reyburn H, Drakeley C, (2012) Candidate human genetic polymorphisms and severe malaria in a Tanzanian population. PLOS ONE. 7: e47463. Epub(2012) Oct 29. doi:10.1371/journal.pone.0047463. PubMed: 23144702.
28. Hasler T, Handunnetti SM, Aguiar JC, van Schravendijk MR, Greenwood BM, et al. (1990) In vitro rosetting, cytoadherence, and microagglutination properties of Plasmodium falciparum infected erythrocytes from Gambian and Tanzanian patients. Blood; 76: 1845-1852. PubMed: 2224132.
29. Ho M, White NJ, (1999) Molecular mechanisms of cytoadherence in malaria. Am J Physiol; 276: C1231-C1242. PubMed: 10362584.
30. Patel SN, Lu Z, Ayi K, Serghides L, Gowda DC, et al. (2007) Disruption of CD36 impairs cytokine response to Plasmodium falciparum glycosylphosphatidylinositol and confers susceptibility to severe and fatal malaria in vivo. J Immunol; 178: 3954-3961. PubMed: 17339496.
31. Verri WA Jr., Cunha TM, Parada CA, Poole S, Cunha FQ, et al. (2006) Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development? Pharmacol Ther 112: 116-138. Epub 10.1016/j.pharmthera.2006.04.001. PubMed: 16730375.
32. Vafa M, Maiga B, Berzins K, Hayano M, Bereczky S, et al. (2007) Associations between the IL-4-590 T allele and Plasmodium falciparum infection prevalence in asymptomatic Fulani of Mali. Microbes Infect 9: 1043-1048. Epub 10.1016/j.micinf.2007.04.011. PubMed: 17662633.
33. Vafa M, Maiga B, Israelsson E, Dolo A, Doumbo OK, et al. (2009). Impact of the IL-4-590 C/T transition on the levels of Plasmodium falciparum specific IgE, IgG, IgG subclasses and total IgE in two sympatric ethnic groups living in Mali. Microbes Infect. 11: 779-84. doi: 10.1016/j.micinf.2009.04.017. Epub 2009 May 4.
34. Turner GD, Morrison H, Jones M, Davis TM, Looareesuwan S, et al. (1994) An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol, 145: 1057-1069. PubMed: 7526692.
35. Armah H, Dodoo AK, Wiredu EK, Stiles JK, Adjei AA et (2005) High-level cerebellar expression of cytokines and adhesion molecules in fatal, paediatric, cerebral malaria. Ann Trop Med Parasitol, 99: 629-647. doi:10.1179/136485905X51508. PubMed: 16212798.
36. Cserti-Gazdewich CM, Dzik WH, Erdman L, Ssewanyana I, Dhabangi, A et; (2010) Combined measurement of soluble and cellular. Retrieved onpublished at whilst December(year 1111) from ICAM-1 among children with Plasmodium falciparum malaria in Uganda. Malar J. 9: 233. doi: 10.1186/1475-2875-9-233.
37. Schleimer RP, Derse CP, Friedman B, Gillis S, Plaut M, et al. (1989) Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids. J Immunol, 143: 1310-1317.
38. Lopez AF, Dyson PG, To LB, Elliott MJ, Milton SE, et al. (1988) Recombinant human interleukin-3 stimulation of hematopoiesis in humans: loss of responsiveness with differentiation in the neutrophilic myeloid series. Blood, 72: 1797-1804. PubMed: 2846093.
39. Meyer CG, Calixto Fernandes MH, Intemann CD, Kreuels B,; Kobbe R, et (2011) IL3 variant on chromosomal region 5q31-33 and protection from recurrent malaria attacks. Hum Mol Genet;20: 1173-1181. Epub(2011) Jan 10. doi:10.1093/hmg/ddq562. PubMed: 21224257.
40. Al-Sherbiny M, Osman A, Barakat R, Morshedy H El, Bergquist R, et al. (2003) In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens. Acta Trop 88: 117-130. doi:10.1016/S0001-706X(03)00195-5. PubMed: 14516923.
41. Leenstra T, Acosta LP, Wu HW, Langdon GC, Solomon JS, et al. (2006) T-helper-2 cytokine responses to Sj97 predict resistance to reinfection with Schistosoma japonicum. Infect Immun 74: 370-381. doi:10.1128/IAI.74.1.370-381.2006. PubMed: 16368992.
42. Ohashi J, Naka I, Patarapotikul J, Hananantachai H, Looareesuwan S, et al. (2003) Tokunaga K. A single-nucleotide substitution from C to T at position-1055 in the IL-13 promoter is associated with protection from severe malaria in Thailand. Genes Immun; 4: 528-531. doi:10.1038/sj.gene.6364010. PubMed: 14551608.
43. Kouriba B, Chevillard C, Bream JH, Argiro L, Dessein H, et al. (2005) Analysis of the 5q31-q33 locus shows an association between IL13-1055C/T IL-13-591A/G polymorphisms and Schistosoma haematobium infections. J Immunol 174: 6274-6281.
44. Clark TG, Diakite M, Auburn S, Campino S, Fry AE, et al. (2009) Tumor necrosis factor and lymphotoxin-alpha polymorphisms and severe malaria in African populations. J Infect Dis 199: 569-575. doi:10.1086/596320. PubMed: 19281305.
45. Diakite M, Clark TG, Auburn S, Campino S, Fry AE, et al.; (2009) A genetic association study in the Gambia using tagging polymorphisms in the major histocompatibility complex class III region implicates a HLA-B associated transcript 2 polymorphism in severe malaria susceptibility. Hum Genet 125: 105-109. Epub(2008) Nov 28. doi:10.1007/s00439-008-0597-2. PubMed: 19039607.
46. Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SL, et al. (2005) Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A 102: 2005-5113. Epub 10.1073/pnas.0408725102. PubMed: 15792998.